Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lauren S Krill

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cancer Journal (Sudbury, Mass.)|March 27, 2013
Robotic surgery: gynecologic oncologyLauren S Krill, Robert E Bristow
Expert Opinion on Pharmacotherapy|February 4, 2015
Integration of bevacizumab with chemotherapy doublets for advanced cervical cancerLauren S Krill, Krishnansu S Tewari
Clinical Therapeutics|January 17, 2015
Exploring the therapeutic rationale for angiogenesis blockade in cervical cancerLauren S Krill, Krishnansu S Tewari
Journal of the American College of Surgeons|October 29, 2008
Value of intraoperative examination of axillary sentinel nodes in carcinoma of the breastGordon F Schwartz, Lauren S Krill, Juan P Palazzo, et al.
Gynecologic Oncology|December 15, 2010
Analysis of postoperative complications associated with the use of anti-adhesion sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier after cytoreductive surgery for ovarian, fallopian tube and peritoneal cancersLauren S Krill, Stefanie M Ueda, Melissa Gerardi, et al.
Gynecologic Oncology Reports|February 7, 2019
A case of ovarian endometrioid adenocarcinoma with yolk sac differentiation and Lynch syndromeJanhvi Sookram, Brooke Levin, Julieta Barroeta, et al.
Obstetrics and Gynecology|June 22, 2011
Disparities in human papillomavirus vaccine completion among vaccine initiatorsBetty Chou, Lauren S Krill, Bernice B Horton, et al.
Current Cancer Drug Targets|January 29, 2014
Molecular targeted approaches to cancer therapy and prevention using chalconesDanielle D Jandial, Christopher A Blair, Saiyang Zhang, et al.
Molecular Cancer|June 15, 2013
Flavokawain B, a kava chalcone, inhibits growth of human osteosarcoma cells through G2/M cell cycle arrest and apoptosisTao Ji, Carol Lin, Lauren S Krill, et al.
Molecules (Basel, Switzerland)|March 25, 2017
Induction of G2M Arrest by Flavokawain A, a Kava Chalcone, Increases the Responsiveness of HER2-Overexpressing Breast Cancer Cells to HerceptinDanielle D Jandial, Lauren S Krill, Lixia Chen, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancer Journal (Sudbury, Mass.)|March 27, 2013
Robotic surgery: gynecologic oncologyLauren S Krill, Robert E Bristow
Expert Opinion on Pharmacotherapy|February 4, 2015
Integration of bevacizumab with chemotherapy doublets for advanced cervical cancerLauren S Krill, Krishnansu S Tewari
Clinical Therapeutics|January 17, 2015
Exploring the therapeutic rationale for angiogenesis blockade in cervical cancerLauren S Krill, Krishnansu S Tewari
Journal of the American College of Surgeons|October 29, 2008
Value of intraoperative examination of axillary sentinel nodes in carcinoma of the breastGordon F Schwartz, Lauren S Krill, Juan P Palazzo, et al.
Gynecologic Oncology|December 15, 2010
Analysis of postoperative complications associated with the use of anti-adhesion sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier after cytoreductive surgery for ovarian, fallopian tube and peritoneal cancersLauren S Krill, Stefanie M Ueda, Melissa Gerardi, et al.
Gynecologic Oncology Reports|February 7, 2019
A case of ovarian endometrioid adenocarcinoma with yolk sac differentiation and Lynch syndromeJanhvi Sookram, Brooke Levin, Julieta Barroeta, et al.
Obstetrics and Gynecology|June 22, 2011
Disparities in human papillomavirus vaccine completion among vaccine initiatorsBetty Chou, Lauren S Krill, Bernice B Horton, et al.
Current Cancer Drug Targets|January 29, 2014
Molecular targeted approaches to cancer therapy and prevention using chalconesDanielle D Jandial, Christopher A Blair, Saiyang Zhang, et al.
Molecular Cancer|June 15, 2013
Flavokawain B, a kava chalcone, inhibits growth of human osteosarcoma cells through G2/M cell cycle arrest and apoptosisTao Ji, Carol Lin, Lauren S Krill, et al.
Molecules (Basel, Switzerland)|March 25, 2017
Induction of G2M Arrest by Flavokawain A, a Kava Chalcone, Increases the Responsiveness of HER2-Overexpressing Breast Cancer Cells to HerceptinDanielle D Jandial, Lauren S Krill, Lixia Chen, et al.
Pageof 1